Fundraising Fox
🦊/People
Sign in

Pascal Merchiers

Chief Development Officer at Mestag Therapeutics

Antwerp Metropolitan Area

Find your path to Pascal

84 people in our graph share verified history with Pascal — schools, employers, funds. One of them is your warm intro.

Issi RozenunlockedPascal: together at Mestag Therapeutics (2025–2026)
×8Pascal: together at KU Leuven
×2Pascal: together at Mestag Therapeutics
Pascal: together at Galapagos NV

Chief Development Officer at Mestag Therapeutics

Intro paths

→

In turn, Pascal can intro founders to Mestag Therapeutics's investors below.

Mestag Therapeutics's investors · 6

ForbionNaarden · since 2026GV (Google Ventures)Mountain View · $250K – $50M checks · since 2026JJDCNew Brunswick · $500K – $5M checks · since 2026Johnson & Johnson Innovation – JJDCNew BrunswickNorthpond VenturesBethesda · $100K – $5M checks · since 2026SV Health InvestorsBoston · $1M – $20M checks · since 2026

Co-founders at Mestag Therapeutics

SHSusan Hill
Susan HillChief Executive Officer
MB
Michael B. BrennerFounder
CB
Chris BuckleyFounder
MCMark Coles
Mark ColesFounder
SR
Soumya RaychaudhuriFounder
DA
David A. TuvesonFounder

Experience

  1. Mestag TherapeuticsChief Development Officer (CDO)current2026 — presentCambridge, England, United Kingdom
  2. Mestag TherapeuticsHead of Development2025Cambridge, England, United Kingdom
  3. BioMerpaOwnercurrent2015 — presentKasterlee, Belgium
  4. Commit BiologicsChief Development Officer (CDO)2023 — 2025Aarhus, Middle Jutland, Denmark
  5. AbolerIS PharmaChief Scientific Officer2023 — 2024Charleroi, Walloon Region, Belgium
  6. Oncurious NVChief Scientific Officer2020 — 2022Leuven, Flemish Region, Belgium
  7. Tusk TherapeuticsVP R&D2015 — 2018Stevenage, UK
  8. ThromboGenics NVHead of Project Development2014Leuven, Belgium
  9. ThromboGenicsSr manager Search and Evaluation2010 — 2014
  10. Ablynx NVProject Manager2005 — 2010
  11. Galapagos NVSenior Scientist2000 — 2005
  12. CrucellSenior Scientist1999 — 2000

Skills & more

Drug DiscoveryBiotechnologyLife SciencesMolecular BiologyLifesciencesProtein ChemistryDrug DevelopmentCellCell BiologyBiopharmaceuticalsAntibodiesImmunology
+4 moreAssay DevelopmentClinical DevelopmentHigh Throughput ScreeningBiochemistry

Languages Dutch · English · French

From Pascal's professional profile.

Frequently asked questions

Who is Pascal Merchiers?
Chief Development Officer at Mestag Therapeutics
Where does Pascal Merchiers work?
Pascal Merchiers is Chief Development Officer at Mestag Therapeutics.
Where did Pascal Merchiers go to school?
Pascal Merchiers studied at KU Leuven (Phd, Biomedical sciences); KU Leuven (certificate of cellular biotechnology, biotechnology).

Same school

Shared employers